[Clinical experiences with the use of dihydroergotamine in gastro-entero-biliary disorders in patients of dystonico-thyroid disorders with hypersympathicotonic background].
D001341:Autonomic Nervous System; D001342:Autonomic Nervous System Diseases; D001659:Biliary Tract; D001660:Biliary Tract Diseases; D004087:Dihydroergotamine; D004194:Disease; D004876:Ergot Alkaloids / Q000628:therapy*; D005705:Gallbladder Diseases; D005762:Gastroenterology / Q000628:therapy*; D005767:Gastrointestinal Diseases; D013959:Thyroid Diseases; D013961:Thyroid Gland
D004876:Ergot Alkaloids; D004087:Dihydroergotamine
AUTONOMIC NERVOUS SYSTEM/diseases; BILIARY TRACT/diseases; ERGOT ALKALOIDS/therapy; GASTROENTEROLOGY/therapy; THYROID GLAND/diseases